insights_auto
Outlook: 73.3% bullish·6.7% bearish
Go to analysischevron_right
CAI:NASDAQ
Caris Life Sciences Inc
$25.57
arrow_upward
+1.35%(+0.34) 1D
$25.37
arrow_downward
-0.77% (-0.20)bedtimeAfter hours
Closed: Nov 9, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 10 analysts giving stock ratings to CAI in the past 3 months
Buy
Buy
7
Hold
3
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CAI in the last 3 months.
Highest
Current $25.57
$38.00 (+48.61%)
Average
$32.78 (+28.20%)
Lowest
$22.00 (-13.96%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Patrick B Donnelly Citi | Buy | Maintained | $36.00 | +40.8% | 11/06/2026 |
Lu Li Bank of America Securities | Buy | Maintained | - | - | 11/05/2026 |
Kyle Mikson CFA Canaccord Genuity | Hold | Maintained | $30.00 | +17.3% | 11/05/2026 |
David Westenberg Piper Sandler | Hold | Maintained | $22.00 | -14% | 11/05/2026 |
Daniel Brennan TD Cowen | Buy | Reiterated | $38.00 | +48.6% | 11/05/2026 |
Evie Koslosky Goldman Sachs | Buy | Maintained | $35.00 | +36.9% | 11/05/2026 |
Catherine Ramsey Schulte Robert W. Baird | Buy | Maintained | $33.00 | +29.1% | 11/05/2026 |
Mark Massaro BTIG | Buy | Maintained | $38.00 | +48.6% | 10/27/2026 |
Casey Woodring J.P. Morgan | Buy | Maintained | $35.00 | +36.9% | 10/14/2026 |
Michael Ryskin Bank of America Securities | Buy | Maintained | $35.00 | +36.9% | 10/09/2026 |
Unknown Analyst UBS | Hold | Initiated | $28.00 | +9.5% | 09/08/2026 |
Doug Schenkel UBS | Hold | Initiated | $28.00 | +9.5% | 09/09/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $26.00 | +1.7% | 08/06/2026 |
Michael Polark Wolfe Research | Hold | Downgraded | - | - | 06/01/2026 |
Unknown Analyst Guggenheim | Buy | Reiterated | $36.00 | +40.8% | 05/11/2026 |
Tycho Peterson Jefferies | Buy | Initiated | $28.00 | +9.5% | 04/12/2026 |